Ticagrelor Concept

subject area of

• A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction  Journal Articles
• A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes  Journal Articles
• Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers  Journal Articles
• Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers  Journal Articles
• Antiplatelet Therapy and Cardiac Surgery: Review of Recent Evidence and Clinical Implications  Journal Articles
• Antithrombotic drug removal from whole blood using Haemoadsorption with a porous polymer bead sorbent  Journal Articles
• Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (COAPT)  Journal Articles
• Contemporary Management of ST-Elevation Myocardial Infarction  Journal Articles
• Determining the price for pharmaceuticals in Germany: comparing a shortcut for IQWiG's efficiency frontier method with the price set by the manufacturer for ticagrelor  Journal Articles
• Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention  Journal Articles
• Effects of ticagrelor versus clopidogrel on platelet function in fibrinolytic-treated STEMI patients undergoing early PCI  Journal Articles
• Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy  Journal Articles
• Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes  Journal Articles
• In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y  Journal Articles
• In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets  Journal Articles
• In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding  Journal Articles
• Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction  Journal Articles
• Long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in fibrinolytic-treated STEMI patients undergoing early PCI  Journal Articles
• Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudy  Journal Articles
• New antithrombotic agents—insights from clinical trials  Journal Articles
• One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial  Journal Articles
• Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial  Journal Articles
• Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future  Journal Articles
• Platelet Transfusion for Ticagrelor Reversal  Journal Articles
• Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study  Journal Articles
• Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies  Journal Articles
• Reversal of the antiplatelet effect of ticagrelor by simulated platelet transfusion  Journal Articles
• Role of phenotypic and genetic testing in managing clopidogrel therapy  Journal Articles
• The Value of Large Randomized Trials of Two Active Interventions to Define the Optimal Treatment in Patients With Acute Coronary Syndrome  Journal Articles
• There seems to be a low risk of experiencing postoperative bleeding in patients undergoing dental extractions or minor oral surgery who continue using antiplatelet therapy  Journal Articles
• Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial  Journal Articles
• Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis  Journal Articles
• Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study  Journal Articles